Upon binding to receptors in immune cells, Type I IFN exhibits potent immunostimulatory effects, stimulating APCs, enhancing cross-priming,36,56 inducing cytolytic T cells,57 and facilitating immune cell-cancer interactions through the production of tumour-CXCL10 and CCL5.58 The gene discussed is CXCL10; the disease is neoplasm.